2024-04-012025-03-312025-03-31false09868551SAMERA PRACTICE SALES LIMITED2025-12-31falseiso4217:GBPxbrli:pure098685512024-03-31098685512025-03-31098685512024-04-012025-03-31098685512023-03-31098685512024-03-31098685512023-04-012024-03-3109868551bus:SmallEntities2024-04-012025-03-3109868551bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3109868551bus:FullAccounts2024-04-012025-03-3109868551bus:PrivateLimitedCompanyLtd2024-04-012025-03-3109868551core:WithinOneYear2025-03-3109868551core:AfterOneYear2025-03-3109868551core:WithinOneYear2024-03-3109868551core:AfterOneYear2024-03-3109868551core:ShareCapital2025-03-3109868551core:SharePremium2025-03-3109868551core:RevaluationReserve2025-03-3109868551core:OtherReservesSubtotal2025-03-3109868551core:RetainedEarningsAccumulatedLosses2025-03-3109868551core:ShareCapital2024-03-3109868551core:SharePremium2024-03-3109868551core:RevaluationReserve2024-03-3109868551core:OtherReservesSubtotal2024-03-3109868551core:RetainedEarningsAccumulatedLosses2024-03-3109868551core:LandBuildings2025-03-3109868551core:PlantMachinery2025-03-3109868551core:Vehicles2025-03-3109868551core:FurnitureFittings2025-03-3109868551core:OfficeEquipment2025-03-3109868551core:NetGoodwill2025-03-3109868551core:IntangibleAssetsOtherThanGoodwill2025-03-3109868551core:ListedExchangeTraded2025-03-3109868551core:UnlistedNon-exchangeTraded2025-03-3109868551core:LandBuildings2024-03-3109868551core:PlantMachinery2024-03-3109868551core:Vehicles2024-03-3109868551core:FurnitureFittings2024-03-3109868551core:OfficeEquipment2024-03-3109868551core:NetGoodwill2024-03-3109868551core:IntangibleAssetsOtherThanGoodwill2024-03-3109868551core:ListedExchangeTraded2024-03-3109868551core:UnlistedNon-exchangeTraded2024-03-3109868551core:LandBuildings2024-04-012025-03-3109868551core:PlantMachinery2024-04-012025-03-3109868551core:Vehicles2024-04-012025-03-3109868551core:FurnitureFittings2024-04-012025-03-3109868551core:OfficeEquipment2024-04-012025-03-3109868551core:NetGoodwill2024-04-012025-03-3109868551core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109868551core:ListedExchangeTraded2024-04-012025-03-3109868551core:UnlistedNon-exchangeTraded2024-04-012025-03-3109868551core:MoreThanFiveYears2024-04-012025-03-3109868551core:Non-currentFinancialInstruments2025-03-3109868551core:Non-currentFinancialInstruments2024-03-3109868551dpl:CostSales2024-04-012025-03-3109868551dpl:DistributionCosts2024-04-012025-03-3109868551core:LandBuildings2024-04-012025-03-3109868551core:PlantMachinery2024-04-012025-03-3109868551core:Vehicles2024-04-012025-03-3109868551core:FurnitureFittings2024-04-012025-03-3109868551core:OfficeEquipment2024-04-012025-03-3109868551dpl:AdministrativeExpenses2024-04-012025-03-3109868551core:NetGoodwill2024-04-012025-03-3109868551core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109868551dpl:GroupUndertakings2024-04-012025-03-3109868551dpl:ParticipatingInterests2024-04-012025-03-3109868551dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3109868551core:ListedExchangeTraded2024-04-012025-03-3109868551dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3109868551core:UnlistedNon-exchangeTraded2024-04-012025-03-3109868551dpl:CostSales2023-04-012024-03-3109868551dpl:DistributionCosts2023-04-012024-03-3109868551core:LandBuildings2023-04-012024-03-3109868551core:PlantMachinery2023-04-012024-03-3109868551core:Vehicles2023-04-012024-03-3109868551core:FurnitureFittings2023-04-012024-03-3109868551core:OfficeEquipment2023-04-012024-03-3109868551dpl:AdministrativeExpenses2023-04-012024-03-3109868551core:NetGoodwill2023-04-012024-03-3109868551core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109868551dpl:GroupUndertakings2023-04-012024-03-3109868551dpl:ParticipatingInterests2023-04-012024-03-3109868551dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3109868551core:ListedExchangeTraded2023-04-012024-03-3109868551dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3109868551core:UnlistedNon-exchangeTraded2023-04-012024-03-3109868551core:NetGoodwill2025-03-3109868551core:IntangibleAssetsOtherThanGoodwill2025-03-3109868551core:LandBuildings2025-03-3109868551core:PlantMachinery2025-03-3109868551core:Vehicles2025-03-3109868551core:FurnitureFittings2025-03-3109868551core:OfficeEquipment2025-03-3109868551core:AfterOneYear2025-03-3109868551core:WithinOneYear2025-03-3109868551core:ListedExchangeTraded2025-03-3109868551core:UnlistedNon-exchangeTraded2025-03-3109868551core:ShareCapital2025-03-3109868551core:SharePremium2025-03-3109868551core:RevaluationReserve2025-03-3109868551core:OtherReservesSubtotal2025-03-3109868551core:RetainedEarningsAccumulatedLosses2025-03-3109868551core:NetGoodwill2024-03-3109868551core:IntangibleAssetsOtherThanGoodwill2024-03-3109868551core:LandBuildings2024-03-3109868551core:PlantMachinery2024-03-3109868551core:Vehicles2024-03-3109868551core:FurnitureFittings2024-03-3109868551core:OfficeEquipment2024-03-3109868551core:AfterOneYear2024-03-3109868551core:WithinOneYear2024-03-3109868551core:ListedExchangeTraded2024-03-3109868551core:UnlistedNon-exchangeTraded2024-03-3109868551core:ShareCapital2024-03-3109868551core:SharePremium2024-03-3109868551core:RevaluationReserve2024-03-3109868551core:OtherReservesSubtotal2024-03-3109868551core:RetainedEarningsAccumulatedLosses2024-03-3109868551core:NetGoodwill2023-03-3109868551core:IntangibleAssetsOtherThanGoodwill2023-03-3109868551core:LandBuildings2023-03-3109868551core:PlantMachinery2023-03-3109868551core:Vehicles2023-03-3109868551core:FurnitureFittings2023-03-3109868551core:OfficeEquipment2023-03-3109868551core:AfterOneYear2023-03-3109868551core:WithinOneYear2023-03-3109868551core:ListedExchangeTraded2023-03-3109868551core:UnlistedNon-exchangeTraded2023-03-3109868551core:ShareCapital2023-03-3109868551core:SharePremium2023-03-3109868551core:RevaluationReserve2023-03-3109868551core:OtherReservesSubtotal2023-03-3109868551core:RetainedEarningsAccumulatedLosses2023-03-3109868551core:AfterOneYear2024-04-012025-03-3109868551core:WithinOneYear2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109868551core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3109868551core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3109868551core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3109868551core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3109868551core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3109868551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3109868551core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3109868551core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3109868551core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3109868551core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3109868551core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3109868551bus:Director12024-04-012025-03-31

SAMERA PRACTICE SALES LIMITED

Registered Number
09868551
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

SAMERA PRACTICE SALES LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

MEHRA, Arun

Company Secretary

MEHRA, Arun

Registered Address

136 High Street
Esher
KT10 9QJ

Registered Number

09868551 (England and Wales)
SAMERA PRACTICE SALES LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors138,639148,671
Cash at bank and on hand444166
139,083148,837
Creditors amounts falling due within one year3(32,797)(23,489)
Net current assets (liabilities)106,286125,348
Total assets less current liabilities106,286125,348
Creditors amounts falling due after one year4(9,218)(26,234)
Net assets97,06899,114
Capital and reserves
Called up share capital1,0001,000
Profit and loss account96,06898,114
Shareholders' funds97,06899,114
The financial statements were approved and authorised for issue by the Director on 31 December 2025, and are signed on its behalf by:
MEHRA, Arun
Director
Registered Company No. 09868551
SAMERA PRACTICE SALES LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The registered office is136-138 High Street, Esher, Surrey, England, KT10 9QJ.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Share capital
The issued share capital of the company comprises 1000 ordinary share of £1, which remains unchanged from the prior year. The share carries equal voting rights, rights to dividends, and rights to a distribution of capital on winding up. This share is wholly owned by Samera Limited.
2.Average number of employees

20252024
Average number of employees during the year11
3.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables24,15023,350
Bank borrowings and overdrafts8,508-
Taxation and social security139139
Total32,79723,489
4.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts9,21826,234
Total9,21826,234
5.Controlling party
The Company is a wholly owned subsidiary of Samera Limited, whose registered office is 136 High Street, Esher, Surrey, England, KT10 9QJ. The ultimate parent company is Eyes of Wonder Limited, which is also registered at 136 High Street, Esher, Surrey, England, KT10 9QJ.